Which has preferable earnings and valuation, INMD or MMED?

InMode has higher earnings, but lower revenue than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $374.64M 2.28 $93.83M $1.36 9.93 MiniMed Group $2.99B 1.40 N/A N/A N/A

Does the media refer more to INMD or MMED?

In the previous week, MiniMed Group had 7 more articles in the media than InMode. MarketBeat recorded 9 mentions for MiniMed Group and 2 mentions for InMode. InMode's average media sentiment score of 0.00 beat MiniMed Group's score of -0.23 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, INMD or WRBY?

InMode has higher earnings, but lower revenue than Warby Parker. InMode is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $374.64M 2.28 $93.83M $1.36 9.93 Warby Parker $871.91M 2.88 $1.64M $0.02 1,173.90

Is INMD or WRBY more profitable?

InMode has a net margin of 23.27% compared to Warby Parker's net margin of 0.15%. InMode's return on equity of 13.47% beat Warby Parker's return on equity. Company Net Margins Return on Equity Return on Assets InMode 23.27% 13.47% 11.95% Warby Parker 0.15% 2.30% 1.18%

Does the media prefer INMD or WRBY?

In the previous week, InMode had 1 more articles in the media than Warby Parker. MarketBeat recorded 2 mentions for InMode and 1 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.79 beat InMode's score of 0.00 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Warby Parker 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings and valuation, TMDX or INMD?

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransMedics Group $605.49M 4.06 $190.29M $4.40 16.17 InMode $374.64M 2.28 $93.83M $1.36 9.93

Does the media favor TMDX or INMD?

In the previous week, TransMedics Group had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for TransMedics Group and 2 mentions for InMode. TransMedics Group's average media sentiment score of 0.25 beat InMode's score of 0.00 indicating that TransMedics Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, LMAT or INMD?

InMode has higher revenue and earnings than LeMaitre Vascular. InMode is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LeMaitre Vascular $249.60M 8.71 $57.73M $2.71 35.10 InMode $374.64M 2.28 $93.83M $1.36 9.93

Does the media prefer LMAT or INMD?

In the previous week, LeMaitre Vascular had 1 more articles in the media than InMode. MarketBeat recorded 3 mentions for LeMaitre Vascular and 2 mentions for InMode. LeMaitre Vascular's average media sentiment score of 0.10 beat InMode's score of 0.00 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, INMD or AXGN?

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $374.64M 2.28 $93.83M $1.36 9.93 AxoGen $225.21M 9.79 -$15.70M -$0.64 N/A

Is INMD or AXGN more profitable?

InMode has a net margin of 23.27% compared to AxoGen's net margin of -13.21%. InMode's return on equity of 13.47% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets InMode 23.27% 13.47% 11.95% AxoGen -13.21% -9.63% -6.26%

Does the media refer more to INMD or AXGN?

In the previous week, AxoGen had 1 more articles in the media than InMode. MarketBeat recorded 3 mentions for AxoGen and 2 mentions for InMode. AxoGen's average media sentiment score of 0.26 beat InMode's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AxoGen 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

InMode (INMD) Competitors

$13.50 -0.04 (-0.30%)

Closing price 06/8/2026 04:00 PM Eastern

Extended Trading

$13.52 +0.02 (+0.11%)

As of 05:40 AM Eastern

Compare

INMD vs. MMED, WRBY, TMDX, LMAT, and AXGN

Should you buy InMode stock or one of its competitors? MarketBeat compares InMode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with InMode include MiniMed Group (MMED), Warby Parker (WRBY), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry.

How does InMode compare to MiniMed Group?

InMode (NASDAQ:INMD) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

68.0% of InMode shares are owned by institutional investors. Comparatively, 19.7% of MiniMed Group shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, MiniMed Group had 7 more articles in the media than InMode. MarketBeat recorded 9 mentions for MiniMed Group and 2 mentions for InMode. InMode's average media sentiment score of 0.00 beat MiniMed Group's score of -0.23 indicating that InMode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

InMode currently has a consensus target price of $16.00, suggesting a potential upside of 18.52%. MiniMed Group has a consensus target price of $21.33, suggesting a potential upside of 43.37%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts clearly believe MiniMed Group is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

InMode has a net margin of 23.27% compared to MiniMed Group's net margin of 0.00%. InMode's return on equity of 13.47% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	23.27%	13.47%	11.95%
MiniMed Group	N/A	N/A	N/A

InMode has higher earnings, but lower revenue than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$374.64M	2.28	$93.83M	$1.36	9.93
MiniMed Group	$2.99B	1.40	N/A	N/A	N/A

Summary

InMode beats MiniMed Group on 7 of the 12 factors compared between the two stocks.

How does InMode compare to Warby Parker?

InMode (NASDAQ:INMD) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, InMode had 1 more articles in the media than Warby Parker. MarketBeat recorded 2 mentions for InMode and 1 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.79 beat InMode's score of 0.00 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

InMode has higher earnings, but lower revenue than Warby Parker. InMode is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$374.64M	2.28	$93.83M	$1.36	9.93
Warby Parker	$871.91M	2.88	$1.64M	$0.02	1,173.90

InMode currently has a consensus target price of $16.00, indicating a potential upside of 18.52%. Warby Parker has a consensus target price of $29.50, indicating a potential upside of 25.65%. Given Warby Parker's stronger consensus rating and higher probable upside, analysts plainly believe Warby Parker is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64

68.0% of InMode shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 6.9% of InMode shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

InMode has a beta of 1.94, meaning that its share price is 94% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market.

InMode has a net margin of 23.27% compared to Warby Parker's net margin of 0.15%. InMode's return on equity of 13.47% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	23.27%	13.47%	11.95%
Warby Parker	0.15%	2.30%	1.18%

Summary

Warby Parker beats InMode on 10 of the 16 factors compared between the two stocks.

How does InMode compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and InMode (NASDAQ:INMD) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

TransMedics Group has a net margin of 27.04% compared to InMode's net margin of 23.27%. TransMedics Group's return on equity of 22.38% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	27.04%	22.38%	8.46%
InMode	23.27%	13.47%	11.95%

In the previous week, TransMedics Group had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for TransMedics Group and 2 mentions for InMode. TransMedics Group's average media sentiment score of 0.25 beat InMode's score of 0.00 indicating that TransMedics Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TransMedics Group currently has a consensus price target of $134.00, indicating a potential upside of 88.36%. InMode has a consensus price target of $16.00, indicating a potential upside of 18.52%. Given TransMedics Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe TransMedics Group is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

TransMedics Group has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market.

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.06	$190.29M	$4.40	16.17
InMode	$374.64M	2.28	$93.83M	$1.36	9.93

Summary

TransMedics Group beats InMode on 13 of the 16 factors compared between the two stocks.

How does InMode compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

LeMaitre Vascular currently has a consensus price target of $112.60, indicating a potential upside of 18.39%. InMode has a consensus price target of $16.00, indicating a potential upside of 18.52%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

LeMaitre Vascular has a net margin of 24.35% compared to InMode's net margin of 23.27%. LeMaitre Vascular's return on equity of 15.36% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
InMode	23.27%	13.47%	11.95%

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, LeMaitre Vascular had 1 more articles in the media than InMode. MarketBeat recorded 3 mentions for LeMaitre Vascular and 2 mentions for InMode. LeMaitre Vascular's average media sentiment score of 0.10 beat InMode's score of 0.00 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InMode has higher revenue and earnings than LeMaitre Vascular. InMode is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	8.71	$57.73M	$2.71	35.10
InMode	$374.64M	2.28	$93.83M	$1.36	9.93

LeMaitre Vascular has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, InMode has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market.

Summary

LeMaitre Vascular beats InMode on 12 of the 17 factors compared between the two stocks.

How does InMode compare to AxoGen?

InMode (NASDAQ:INMD) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$374.64M	2.28	$93.83M	$1.36	9.93
AxoGen	$225.21M	9.79	-$15.70M	-$0.64	N/A

InMode currently has a consensus target price of $16.00, indicating a potential upside of 18.52%. AxoGen has a consensus target price of $46.50, indicating a potential upside of 12.16%. Given InMode's higher possible upside, research analysts plainly believe InMode is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

68.0% of InMode shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 2.4% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

InMode has a net margin of 23.27% compared to AxoGen's net margin of -13.21%. InMode's return on equity of 13.47% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	23.27%	13.47%	11.95%
AxoGen	-13.21%	-9.63%	-6.26%

In the previous week, AxoGen had 1 more articles in the media than InMode. MarketBeat recorded 3 mentions for AxoGen and 2 mentions for InMode. AxoGen's average media sentiment score of 0.26 beat InMode's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AxoGen	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

InMode has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

Summary

InMode beats AxoGen on 10 of the 16 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INMD vs. The Competition

Export

Metric	InMode	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$857.88M	$8.40B	$6.48B	$11.99B
Dividend Yield	N/A	2.52%	2.67%	5.58%
P/E Ratio	9.93	16.16	23.69	23.74
Price / Sales	2.28	7.12	513.81	108.85
Price / Cash	9.08	17.45	26.99	37.25
Price / Book	1.25	3.55	10.41	6.78
Net Income	$93.83M	$225.32M	$3.57B	$337.51M
7 Day Performance	N/A	0.58%	0.28%	-2.34%
1 Month Performance	-3.30%	2.21%	3.27%	1.88%
1 Year Performance	-7.28%	-3.45%	22.25%	25.55%

InMode Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INMD InMode	2.1079 of 5 stars	$13.50 -0.3%	$16.00 +18.5%	-4.7%	$857.88M	$374.64M	9.93	480
MMED MiniMed Group	3.4515 of 5 stars	$12.00 -0.3%	$21.67 +80.6%	N/A	$3.37B	$2.99B	N/A	8,000	Earnings Report
WRBY Warby Parker	4.432 of 5 stars	$24.43 -0.4%	$29.50 +20.8%	+8.7%	$2.63B	$871.91M	1,222.11	4,036	Positive News Gap Up
TMDX TransMedics Group	4.5212 of 5 stars	$67.53 +0.5%	$134.00 +98.4%	-48.8%	$2.32B	$605.49M	15.35	210
LMAT LeMaitre Vascular	4.6027 of 5 stars	$91.42 -3.4%	$112.60 +23.2%	+13.1%	$2.16B	$249.60M	33.73	490

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INMD) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InMode (INMD) Competitors

INMD vs. MMED, WRBY, TMDX, LMAT, and AXGN

How does InMode compare to MiniMed Group?

Summary

How does InMode compare to Warby Parker?

Summary

How does InMode compare to TransMedics Group?

Summary

How does InMode compare to LeMaitre Vascular?

Summary

How does InMode compare to AxoGen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InMode (INMD) Competitors

INMD vs. MMED, WRBY, TMDX, LMAT, and AXGN

How does InMode compare to MiniMed Group?

Do insiders and institutionals have more ownership in INMD or MMED?

Does the media refer more to INMD or MMED?

Do analysts rate INMD or MMED?

Is INMD or MMED more profitable?

Which has preferable earnings and valuation, INMD or MMED?

Summary

How does InMode compare to Warby Parker?

Does the media prefer INMD or WRBY?

Which has higher valuation and earnings, INMD or WRBY?

Do analysts recommend INMD or WRBY?

Do insiders and institutionals hold more shares of INMD or WRBY?

Which has more volatility and risk, INMD or WRBY?

Is INMD or WRBY more profitable?

Summary

How does InMode compare to TransMedics Group?

Is TMDX or INMD more profitable?

Does the media favor TMDX or INMD?

Do analysts prefer TMDX or INMD?

Which has more risk and volatility, TMDX or INMD?

Do insiders & institutionals believe in TMDX or INMD?

Which has stronger earnings and valuation, TMDX or INMD?

Summary

How does InMode compare to LeMaitre Vascular?

Do analysts recommend LMAT or INMD?

Is LMAT or INMD more profitable?

Do institutionals and insiders believe in LMAT or INMD?

Does the media prefer LMAT or INMD?

Which has stronger valuation & earnings, LMAT or INMD?

Which has more volatility & risk, LMAT or INMD?

Summary

How does InMode compare to AxoGen?

Which has higher valuation & earnings, INMD or AXGN?

Do analysts rate INMD or AXGN?

Do institutionals and insiders believe in INMD or AXGN?

Is INMD or AXGN more profitable?

Does the media refer more to INMD or AXGN?

Which has more risk and volatility, INMD or AXGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools